$1.5 billion investment in pharma sector planned by Jordan

8 February 2011

With the aim of taking the industry to broader international horizons, Jordan established a union for pharmaceuticals and medical supplies' manufacturers in 1996, with also a main objective of increasing Jordanian exports to strict markets such as in the USA and Europe. This would lead to increase in interaction with international pharmaceuticals and provide partnership opportunities, reports the Global Arab Network, noting that the country is investing some $1.5 billion in the pharmaceutical sector.

Board Chairman of the union, Adnan Badwan, told the news service that the increase in adoption and expansion of national health insurance and health care schemes in the Arab region and the Middle East provides further potential of growth in demand.

Jordanians have an advantage due to their expertise and high quality of their product should such new opportunities arise, and the Jordanian example of seeking self-sufficiency in pharmaceutical products is also attractive to other states in the region, which could request cooperation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical